CN102670479A - 中药消炎拔痘美容霜及其制备方法 - Google Patents
中药消炎拔痘美容霜及其制备方法 Download PDFInfo
- Publication number
- CN102670479A CN102670479A CN2012101568592A CN201210156859A CN102670479A CN 102670479 A CN102670479 A CN 102670479A CN 2012101568592 A CN2012101568592 A CN 2012101568592A CN 201210156859 A CN201210156859 A CN 201210156859A CN 102670479 A CN102670479 A CN 102670479A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- cosmetic cream
- extract
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 90
- 239000008278 cosmetic cream Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 206010000496 acne Diseases 0.000 title abstract description 23
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract description 13
- 239000002260 anti-inflammatory agent Substances 0.000 title abstract 7
- 230000001741 anti-phlogistic effect Effects 0.000 title abstract 7
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 23
- 239000000284 extract Substances 0.000 claims description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 36
- 239000000843 powder Substances 0.000 claims description 26
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 24
- 244000293323 Cosmos caudatus Species 0.000 claims description 22
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 22
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 19
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 19
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 18
- 239000001569 carbon dioxide Substances 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 230000001476 alcoholic effect Effects 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 235000008216 herbs Nutrition 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 241000186427 Cutibacterium acnes Species 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 235000019260 propionic acid Nutrition 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 229910052602 gypsum Inorganic materials 0.000 abstract description 2
- 239000010440 gypsum Substances 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 208000020154 Acnes Diseases 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000002085 irritant Substances 0.000 abstract 1
- 231100000021 irritant Toxicity 0.000 abstract 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 1
- 230000000452 restraining effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000003809 water extraction Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 40
- 241000700647 Variola virus Species 0.000 description 23
- 239000011148 porous material Substances 0.000 description 10
- 230000003255 anti-acne Effects 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 240000005373 Panax quinquefolius Species 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 4
- 241000018646 Pinus brutia Species 0.000 description 4
- 235000011613 Pinus brutia Nutrition 0.000 description 4
- 206010037888 Rash pustular Diseases 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 231100000957 no side effect Toxicity 0.000 description 4
- 208000029561 pustule Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 240000003864 Ulex europaeus Species 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000002189 macula lutea Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 240000007371 Cuscuta campestris Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 244000126002 Ziziphus vulgaris Species 0.000 description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- FSSVRLXFJPQUTM-WCCKRBBISA-N 2-aminoacetic acid;(2s)-2-amino-4-methylsulfanylbutanoic acid Chemical compound NCC(O)=O.CSCC[C@H](N)C(O)=O FSSVRLXFJPQUTM-WCCKRBBISA-N 0.000 description 1
- 244000258395 Allamanda cathartica Species 0.000 description 1
- 241001506940 Alpinia japonica Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 241000737241 Cocos Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 241001478744 Disporopsis pernyi Species 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010048810 Sebaceous hyperplasia Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 241000982977 Taraxacum stanjukoviczii Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- -1 anti-acne Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 210000003859 smegma Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种中药消炎拔痘美容霜及其制备方法,包括中药组分和重量份数:蒲公英25-35份、黄莲6-15份、玉竹8-15份、茯苓15-20份、红枣15-20份、槐花10-20份、石膏10-20份和珍珠2-8份。具有强力清除皮层及体内游离脂肪酸,抑制和杀灭丙酸痤疮棒状杆菌活性,促进营养成分的吸收,促进肌肤新陈代谢,能标本兼治,无毒副作用,对皮肤无刺激性令肌肤恢复弹性及活力,达到消炎、拔痘和美容的功效。其制备方法采用超临界萃取和水提方法结合,能够有效提取中药有效部位成分,提高中药的功能,并节约有限而价高中药资原,具有较好的经济效益和社会效益。
Description
技术领域
本发明属于日用化工技术领域,涉及一种中药消炎拔痘美容霜及其制备方法。
背景技术
西医认为痘痘一般是因为体内雄性激素分泌增多或相对增高,刺激皮脂腺增生肥大,分泌油脂量上升。另外痘痘的病因还与一些病原菌感染有关,已经证实的痘痘与丙酸痤疮棒状杆菌感染有关。这种棒状杆菌寄生于青春期的毛囊皮脂腺里,通过脂酶的催化作用,会水解产生甘油三脂和较多的游离脂肪酸,这些游离脂肪酸能使毛囊及毛囊周围发生非特异性炎症反应。
中医学认为皮肤是五脏的“镜子”,皮肤表面的痘痘与人的五脏六腑关系密切,中医医学研究表明:痘痘虽然生长在皮肤表面,但与脏腑功能失调息息相关。本病常由肺经风热阻于肌肤所致;或因过食肥甘、油腻、辛辣食物,脾胃蕴热,湿热内生,熏蒸于面而成;或因青春之体,血气方刚,阳热上升,与风寒相搏,郁阻肌肤所致。体内的荷尔蒙会刺激毛发生长,皮脂腺分泌旺盛,导致毛孔堵塞形成一个粉刺的核心——微粉刺。微粉刺是看不见的,一个微粉刺从形成到长出皮肤表面需要6到9个月的生长期。微粉刺堵塞毛孔诱发炎症,是丘疹、脓包、结节和囊肿的始发根源!传统治疗只是清除表面的粉刺,而微粉刺停一段时间又长出来!于是形成了痤疮反复发作的局面,造成皮脂腺长期分泌、皮脂旺盛长期长痘的原因是内分泌,专业祛除青春痘的产品主要是调节内分泌失调。阻止微粉刺在形成。所以治暗疮,青春痘,微粉刺是关键!没有微粉刺就没有粉刺,没有粉刺就没有暗疮、青春痘!
随着人们生活水平的提高,现代人对于美的追求也越来越高,在人们追求绿色化妆品、回归自然的心理日益增强,天然活性化妆品顺应回归大自然的发展潮流和人们的消费心理。以无毒无副作用的天然产物为活性添加剂和化妆品原料的化妆用品成为精细化学品行业一大热点,安全、无副作用的美白产品应运而生,一些具有很好的美白效果的中草药目前越来越受到消费者的青昧,是化妆品“绿色”21世纪的主题。目前,市面上祛痘的产品很多如:祛痘洗面奶、祛痘面膜、祛痘液,祛痘精油等等,很多祛痘产品其主要成分是中草药植物,运用清爽控油预防痘痘产生,慢慢调理肌肤的内部环境最终达到祛痘的目的。清洁是护肤的第一步,也是抗痘的第一步,如果从第一步就忽略或者选错洁面产品,出油、毛孔粗大、痘痘等肌肤问题只会更加严重,肌肤也会变得越来越脆弱,抗痘也会变得相对比较困难,因为毛孔的堵塞也会阻碍祛痘产品的吸收。
中国专利申请号CN200710120917.5,祛痘配方。该配方包括30份苦杏仁、20份珍珠粉、5份牛黄、50份防风、30份蛇蜕、26份白芍、40份金银花、100份意米仁、60份桃仁、100份蛇 脂和20份人参。该配方可以实现祛痘、祛印、美白和控油等多重功效,且无副作用。
祛痘产品应该能够有效打开阻塞毛孔,促进代谢,调理油脂分泌,平衡肌肤pH值,快速杀菌、清洁毛孔,清理皮层同时能避免痘痘肌肤不适感,敏感皮肤也可安心使用。
发明内容
本发明的目的是:一是采用纯天然材料制成,气味清香,且无刺激,无过敏反应,使药物能迅速渗透至肌肤内层,促进营养成分的吸收,促进肌肤新陈代谢,清除皮层及体内游离脂肪酸,抑制和杀灭丙酸痤疮棒状杆菌活性,令肌肤恢复活力;二是克服现有的制备方法存在的其提取率低,不能将某些高沸点药物的成分全部提取使用,低挥发度药物的挥发性成分容易逸散,药材的有效成分损失大的不足而提供一种中药消炎拔痘美容霜及其制备方法。
本发明的技术方案为:
本发明根据中医学理论用中药清除皮层及体内游离脂肪酸,抑制或杀灭丙酸痤疮棒状杆菌活性,促进局部血液循环,改善局部皮肤代谢,使肌肤恢复活力。选用能够清热解毒,消痈散结,凉血养血,收敛止血,消肿生肌,生肌止痛,抗菌和杀灭丙酸痤疮棒状杆菌活性,清除游离脂肪酸,改善人体微循环,促进皮肤新陈代谢,使肌肤恢复活力中药材的家传秘方,并采用超临界萃取和水提方法结合,提取中药有效部位成分,制备具有消炎拔痘美容霜。
本发明采用的中药物药理
1、蒲公英:蒲公英(Taraxacum stanjukoviczii Schischk),别名:蒲公草、食用蒲公英、尿床草、西洋蒲公英、黄花地丁、婆婆丁、奶汁草。味苦、甘、涩,性寒,归肺、肝、胃经。具有清热解毒,消肿散结,利尿通淋功效。用于疔疮肿毒,乳痈,瘰疠,目赤,咽痛,肺痈,肠痈,湿热黄疸,热淋涩痛。
2、黄莲:黄莲(Radix Berberidis Virgetori),别名:川连、姜连、川黄连、姜黄连、姜川连、姜制黄连、萸连、萸黄连、炒黄连、吴萸黄连、酒连、酒黄连、酒饮连、猪胆汁炒黄连、盐炒黄连、黄连炭、姜汁炒川连、尾连等。味苦,性寒。归心、脾、胃、肝、胆、大肠经。具有清热燥湿,泻火解毒功效。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热。用于目赤,口疮。
3、玉竹:玉竹(Rhizoma Polygonati Odorati),别名:委萎、女萎、萎、葳蕤、王马、节地、虫蝉、乌萎、青粘、黄芝、地节、萎蕤、马熏、葳参、玉术、山玉竹、笔管子、十样错、竹七根、竹节黄、黄脚鸡、百解药、山姜、黄蔓菁、尾参、连竹、西竹、山苞米。味甘,性微寒。归肺、胃经。具有养阴润燥,生津止渴功效。用于肺胃阴伤,燥热咳嗽,咽干口渴,内热消渴。
4、茯苓:茯苓(Poria cocos(Fr.)Wolf.),别名:茯菟、茯灵、茯蕶、伏苓、伏菟、松腴、绛晨伏胎、云苓、茯兔、松薯、松木薯、松苓。味甘、淡,性平。归心、肺、脾、肾经。具有利水渗湿,健脾宁心功效。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。
5、红枣:红枣(Ziziphus jujuba Mill.),别名:大枣、干枣、枣子。味甘,性温。归脾、胃经。具有补中益气,养血安神功效。用于脾虚食少,乏力便溏,妇人脏躁。
6、槐花:槐花(Sophora japonica L.),味苦,性微寒。归肝、大肠经。具有凉血止血,清肝泻火功效。用于便血,痔血,血痢,崩漏,吐血,衄血,肝热目赤,头痛眩晕。
7、石膏:石膏(Gypsum Fibrosuum),石膏为硫酸盐类矿物,主含含水硫酸钙(CaSO4·2H2O)。味甘、性辛,大寒。归肺、胃经。具有清热泻火,除烦止渴功能。用于外感热病,高热烦渴,肺热喘咳,胃火亢盛,头痛,牙痛。
8、珍珠:珍珠(Pernulo),珍珠味咸甘寒无毒。珍珠的主要成份为碳酸钙,经现代医学研究证明,珍珠富含人体所需多种氨基酸如亮氨酸、甘氨酸蛋氨酸、丙氨酸、谷氨酸、天冬氨酸和20多种微量元素如铁、铜、镁、锌、锰、钠、硒等,能有效参与并促进人体生命活动,调节内分泌,调理体内平衡,调养气血,滋润皮肤。珍珠的锰、铜、锌等三种微量元素是组成SOD的成分,用珍珠粉涂面,可促进人体肌肤超氧化物歧化酶(SOD)的活性,具有美白、控油、祛痘、去黑头、淡斑、生肌功效。
本发明是这样实现的:
中药消炎拔痘美容霜,中药组分和重量份数:蒲公英25-35份、黄莲6-15份、玉竹8-15份、茯苓15-20份、红枣15-20份、槐花10-20份、石膏10-20份和珍珠2-8份。
以上所述的中药消炎拔痘美容霜,中药组分和重量份数:蒲公英30份、黄莲10份、玉竹10份、茯苓18份、红枣18份、槐花15份、石膏15份和珍珠5份。
以上所述的石膏和珍珠采用市售粉剂或采用常规技术加工成粉未。
以上所述的中药消炎拔痘美容霜的制备方法,包括中药有效成分提取、脱色和制备霜剂,所述的中药有效成分提取是采用二氧化碳超临界萃取和回流水提两步法提取,先将原料中药粉碎成粗粉,经二氧化碳超临界萃取得到超临界萃取物,药渣用水回流煎煮后过滤,滤液浓缩得到水提取物,合并二氧化碳超临界萃取物和水提取物得到中药提取物;所述的脱色是将中药提取物溶于乙醇水溶液中,加入活性炭脱色,过滤,浓缩得到中药清膏,再制备中药中药消炎拔痘美容霜,其步骤如下:
1、粉碎:将干净植物中药用粉碎机粉碎成30-60目中药粗粉备用;
2、超临界萃取:将中药粗粉投入超临界萃取器中进行二氧化碳超临界萃取得到超临界萃 取物;
3、水提:经超临界萃取的药渣投入回流蒸煮锅中,加水回流水提后,过滤,浓缩得到水煮提取物;
4、脱色:将中药超临界萃取物和水煮提取物溶于乙醇水溶液中,加入活性炭脱色,过滤,浓缩得到中药提取物,回收活性炭;
5、混合:将中药提取物、石膏和珍珠采用常规基质和制备方法乳化,均质得到中药中药消炎拔痘美容霜。
以上所述的二氧化碳超临界萃取的萃取压力为12-35Mpa,萃取温度为30-50℃,萃取时间为0.5-2小时,二氧化碳流量为16-40kg/小时;
以上所述的回流水提控制温度85-100℃,水煮时间为1-2.5小时;
以上所述的乙醇水溶液的醇浓度为45-80%;
以上所述的浓缩采用真空浓缩,控制温度55-80℃,回收醇溶液。
本发明的优点和积极效果:
1、本品采用中药为原料,克服了传统的消炎拔痘霜,拔痘祛斑效果较差,且含有化学合成物,刺激性较大,气味较差的缺点。具有标本兼治,无毒副作用,对皮肤无刺激性,乳液颗粒细腻,涂布均匀,手感油滑,铺展性好。具有强力清除皮层及体内游离脂肪酸,抑制和杀灭丙酸痤疮棒状杆菌活性,促进营养成分的吸收,促进肌肤新陈代谢,令肌肤恢复弹性及活力,达到消炎、拔痘、美容的功效。
2、本制备方法采用超临界萃取和水提方法结合,克服了现有的中药物拔痘霜由于其有效成分提取用水蒸汽蒸馏法制备工艺存弊端,提取率较高,能将某些高沸点和低挥发度的成分全部提取出来,而且药物的挥发性成分不容易逸散,易热解的物质或化学不稳定性成分得到保护,药物的有效成分损失较少,能够有效提取中药有效部位成分,提高中药的功能,并节约有限而价高中药资原,具有较好的经济效益和社会效益。
具体实施方式
以下结合实施例对本发明作进一步详细描述,所列实施例仅在于说明本发明而绝不限于本发明。
实施例1
(一)中药组分:
蒲公英3公斤、黄莲1公斤、玉竹1公斤、茯苓1.8公斤、红枣1.8公斤、槐花1.5公斤、石膏1.5公斤和珍珠0.5公斤。
(二)制备方法:
将干净植物中药用粉碎机粉碎成40目中药粗粉,将中药粗粉投入超临界萃取器中进行二氧化碳超临界萃取,萃取压力为12.5Mpa,萃取温度为50℃,萃取时间为1小时,二氧化碳流量为40kg/小时得到超临界萃取物;经超临界萃取的药渣投入回流蒸煮锅中,加水再回流水提,回流水提控制温度100℃,时间为1小时,然后按常规方法过滤,进行真空浓缩,制温度55℃进行真空浓缩,得到水煮提取物,回收醇溶液;将中药超临界萃取物和水煮提取物溶于浓度为50%的乙醇水溶液中,加入活性炭脱色,过滤,采用常规真空浓缩得到中药提取物,回收活性炭和乙醇;将中药提取物、石膏粉和珍珠粉采用常规基质和制备方法乳化,均质得到中药中药消炎拔痘美容霜。
实施例2
(一)中药组分:
公英2.5公斤、黄莲1.3公斤、玉竹1.3公斤、茯苓1.5公斤、红枣1.8公斤、槐花1.2公斤、石膏1.2公斤和珍珠0.7公斤。
(二)制备方法:
将干净植物中药用粉碎机粉碎成60目中药粗粉,将中药粗粉投入超临界萃取器中进行二氧化碳超临界萃取,萃取压力为35Mpa,萃取温度为30℃,萃取时间为0.5小时,二氧化碳流量为36kg/小时得到超临界萃取物;经超临界萃取的药渣投入回流蒸煮锅中,加水再回流水提,回流水提控制温度85℃,时间为2.5小时,然后按常规方法过滤,控制温度70℃进行真空浓缩,得到水煮提取物,回收醇溶液;将中药超临界萃取物和水煮提取物溶于浓度为70%的乙醇水溶液中,加入活性炭脱色,过滤,采用常规真空浓缩得到中药提取物,回收活性炭和乙醇;将中药提取物、石膏粉和珍珠粉采用常规基质和制备方法乳化,均质得到中药中药消炎拔痘美容霜。
实施例3
(一)中药组分:
蒲公英3.5公斤、黄莲0.8公斤、玉竹1.3公斤、茯苓1.6公斤、红枣2公斤、槐花2公斤、石膏1.7公斤和珍珠0.3公斤。
将干净植物中药用粉碎机粉碎成60目中药粗粉,将中药粗粉投入超临界萃取器中进行二氧化碳超临界萃取,萃取压力为25Mpa,萃取温度为35℃,萃取时间为1小时,二氧化碳流量为20kg/小时得到超临界萃取物;经超临界萃取的药渣投入回流蒸煮锅中,加水再回流水提,回流水提控制温度90℃,时间为2小时,然后按常规方法过滤,控制温度75℃进行真空浓缩,得到水煮提取物,回收醇溶液;将中药超临界萃取物和水煮提取物溶于浓度为60%的乙醇水溶液中,加入活性炭脱色,过滤,采用常规真空浓缩得到中药提取物,回收活性炭和 乙醇;将中药提取物、石膏粉和珍珠粉采用常规基质和制备方法乳化,均质得到中药中药消炎拔痘美容霜。
应用实例
1、黄XX,女性,年龄:24,职业:公司文员。皮肤症状:重度痘痘、红肿、有脓包,面部痘印覆盖面积大,使用前:痘痘密集、大而红肿、脓包过多。使用本实施例1产品,采取每天早、中、晚三次在脸上涂抹,特别针对痘痘有脓包先针刺放有脓后涂抹,连同红肿部位反复多次擦试增加霜量,3天疼痛感减轻,红肿的痘痘表面干瘪;20天痘痘得到了初步抑制,慢慢减少,痘痘表皮结茄脱落,痘印逐渐变淡;坚持用40天痘痘得到抑制,痘印大部分消失,皮肤渐渐平滑白皙,红润光泽。
2、董X,女性,年龄:21,在校大学生。皮肤症状:自从17岁开始四年多顽逗久治不愈,使用前,毛孔粗大,痘痘不断复发,特别是月经前更是满脸痘痘,长期形成面部皮肤痘印难除。使用本实施例2产品,采取敷脸的方式每天早、中、晚各一次,每次30分钟之后用粉纸将吸收多余部分擦除。使用7天毛孔收缩细腻,痘痘表面干瘪;14天皮肤水油恢复平衡,痘痘明显减少;21天痘印变淡,痘痘基本没有复发;坚持用两个月60天痘痘基本消除,痘印消除80%以上,面部皮肤活力增强,皮肤红润平滑有光泽,多年的顽逗得以治愈。
3、韦XX,男性,年龄:26,职业:企业管理。皮肤症状:毛孔粗大,油脂旺盛,脸庞有大面积痘痘,鼻子两侧长黑头,使用前,满面油光,带有红肿疼痛。使用本实施例2产品,每天早晚各涂抹一次30分钟,三天后红肿疼痛感觉减轻;八天后痘痘、粉刺开始萎缩,面部油性降低;14天黑头脱落,红肿消失疼痛感完全没有;21天后油光消除,痘印淡化;连续用49天皮肤毛孔细腻平滑,痘印无痕、油光消失,黑头、痘痘再无复发,痘痘得到了有效地抑制。
4、陆XX:女性,年龄25岁,职业:小学老师。皮肤症状:面部皮肤皮肤粗糙,无光滑,无弹性,长青春痘,有黄斑。试用本实施例3产品,每天晚上温水清洗面部再擦本实施例3产品,开始一周无明显变化;两周后面部皮肤得到改善,青春痘生长数量得到抑制;使用五周天面部皮肤活力增强,皮肤粗糙感得到改善,黄斑减少;坚持使用十周后面部皮肤变润滑细嫩,黄斑和青春痘消失,皮肤红润有光泽。
Claims (8)
1.一种中药消炎拔痘美容霜,其特征在于:包括中药组分和重量份数:蒲公英25~35份、黄莲6-15份、玉竹8-15份、茯苓15-20份、红枣15-20份、槐花10-20份、石膏10-20份和珍珠2-8份。
2.根据权利要求1所述的中药消炎拔痘美容霜,其特征在于:中药组分和重量份数:蒲公英30份、黄莲10份、玉竹10份、茯苓18份、红枣18份、槐花15份、石膏15份和珍珠5份。
3.根据权利要求1所述的中药消炎拔痘美容霜,其特征在于:所述的石膏和珍珠采用市售粉剂或采用常规技术加工成粉未。
4.根据权利要求1或2所述的中药消炎拔痘美容霜的制备方法,包括中药有效成分提取、脱色和制备霜剂,其特征在于:所述的中药有效成分提取是采用二氧化碳超临界萃取和回流水提两步法提取,先将原料中药粉碎成粗粉,经二氧化碳超临界萃取得到超临界萃取物,药渣用水回流煎煮后过滤,滤液浓缩得到水提取物,合并二氧化碳超临界萃取物和水提取物得到中药提取物;所述的脱色是将中药提取物溶于乙醇水溶液中,加入活性炭脱色,过滤,浓缩得到中药清膏,再制备中药中药消炎拔痘美容霜,其步骤如下:
(1)粉碎:将干净植物中药用粉碎机粉碎成30-60目中药粗粉备用;
(2)超临界萃取:将中药粗粉投入超临界萃取器中进行二氧化碳超临界萃取得到超临界萃取物;
(3)水提:经超临界萃取的药渣投入回流蒸煮锅中,加水回流水提后,冷却,过滤,浓缩得到水煮提取物;
(4)脱色:将中药超临界萃取物和水煮提取物溶于乙醇水溶液中,加入活性炭脱色,过滤,浓缩得到中药提取物,回收活性炭;
(5)混合:将中药提取物、石膏和珍珠采用常规基质和制备方法乳化,均质得到中药中药消炎拔痘美容霜。
5.根据权利要求4所述的中药消炎拔痘美容霜的制备方法,其特征在于:所述的二氧化碳超临界萃取的萃取压力为12-35Mpa,萃取温度为30-50℃,萃取时间为0.5-2小时,二氧化碳流量为16-40kg/小时;
6.根据权利要求4所述的中药消炎拔痘美容霜的制备方法,其特征在于:所述的回流水提控制温度85-100℃,水煮时间为1-2.5小时;
7.根据权利要求4所述的中药消炎拔痘美容霜的制备方法,其特征在于:所述的乙醇水溶液的醇浓度为45-80%;
8.根据权利要求4所述的中药消炎拔痘美容霜的制备方法,其特征在于:所述的浓缩采用真空浓缩,控制温度55-80℃,回收醇溶液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210156859 CN102670479B (zh) | 2012-05-21 | 2012-05-21 | 中药消炎拔痘美容霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210156859 CN102670479B (zh) | 2012-05-21 | 2012-05-21 | 中药消炎拔痘美容霜及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102670479A true CN102670479A (zh) | 2012-09-19 |
CN102670479B CN102670479B (zh) | 2013-05-08 |
Family
ID=46803478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210156859 Active CN102670479B (zh) | 2012-05-21 | 2012-05-21 | 中药消炎拔痘美容霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102670479B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446483A (zh) * | 2013-09-04 | 2013-12-18 | 王建波 | 一种治疗肺经风热型痤疮的中药组合物 |
CN105816400A (zh) * | 2016-06-12 | 2016-08-03 | 马殿伟 | 一种含有柽柳的用于祛痘化妆品的中药组合物 |
DK201600316A1 (en) * | 2016-05-27 | 2017-12-11 | Tingen Tech Co Ltd | Chinese drugs pharmaceutics for pimple scar elimination and the preparation method thereof |
CN107595728A (zh) * | 2017-08-18 | 2018-01-19 | 苏州莱奥生物技术有限公司 | 一种中药袪痘美白霜 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04139132A (ja) * | 1990-09-28 | 1992-05-13 | Asahi Breweries Ltd | 抗活性酸素作用組成物並びにこれを有効成分とする抗活性酸素剤、食品、化粧料及び医薬品 |
WO2001041715A2 (en) * | 1999-12-02 | 2001-06-14 | The C.P. Hall Company | Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
CN1626170A (zh) * | 2003-12-08 | 2005-06-15 | 赵传水 | 一种具有去斑去痘作用的中药的配方及制备方法 |
US6936267B2 (en) * | 2002-04-25 | 2005-08-30 | William O. Kling | Anti-acne compositions and methods of use |
JP3771199B2 (ja) * | 2001-08-10 | 2006-04-26 | 株式会社カネボウ化粧品 | 化粧料 |
CN101259172A (zh) * | 2007-03-06 | 2008-09-10 | 上海家化联合股份有限公司 | 用于治疗痤疮的中药组合物、其制备方法以及应用 |
CN102018937A (zh) * | 2010-12-14 | 2011-04-20 | 金亮亮 | 一种治疗痤疮的药物及制备方法 |
-
2012
- 2012-05-21 CN CN 201210156859 patent/CN102670479B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04139132A (ja) * | 1990-09-28 | 1992-05-13 | Asahi Breweries Ltd | 抗活性酸素作用組成物並びにこれを有効成分とする抗活性酸素剤、食品、化粧料及び医薬品 |
WO2001041715A2 (en) * | 1999-12-02 | 2001-06-14 | The C.P. Hall Company | Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
JP3771199B2 (ja) * | 2001-08-10 | 2006-04-26 | 株式会社カネボウ化粧品 | 化粧料 |
US6936267B2 (en) * | 2002-04-25 | 2005-08-30 | William O. Kling | Anti-acne compositions and methods of use |
CN1626170A (zh) * | 2003-12-08 | 2005-06-15 | 赵传水 | 一种具有去斑去痘作用的中药的配方及制备方法 |
CN101259172A (zh) * | 2007-03-06 | 2008-09-10 | 上海家化联合股份有限公司 | 用于治疗痤疮的中药组合物、其制备方法以及应用 |
CN102018937A (zh) * | 2010-12-14 | 2011-04-20 | 金亮亮 | 一种治疗痤疮的药物及制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446483A (zh) * | 2013-09-04 | 2013-12-18 | 王建波 | 一种治疗肺经风热型痤疮的中药组合物 |
DK201600316A1 (en) * | 2016-05-27 | 2017-12-11 | Tingen Tech Co Ltd | Chinese drugs pharmaceutics for pimple scar elimination and the preparation method thereof |
CN105816400A (zh) * | 2016-06-12 | 2016-08-03 | 马殿伟 | 一种含有柽柳的用于祛痘化妆品的中药组合物 |
CN107595728A (zh) * | 2017-08-18 | 2018-01-19 | 苏州莱奥生物技术有限公司 | 一种中药袪痘美白霜 |
Also Published As
Publication number | Publication date |
---|---|
CN102670479B (zh) | 2013-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105997836B (zh) | 一种酵素洗发水及其配制方法 | |
CN102028752B (zh) | 中草药复方祛斑美白组合物及外用制剂 | |
CN103906526A (zh) | 利用药用花的包裹发酵方法及利用其的皮肤外用剂组合物 | |
CN103266040B (zh) | 美容保健酒 | |
CN106236677A (zh) | 一种养发护发生发茶麸纯植物酵素洗发液及其制备方法 | |
CN105213284A (zh) | 一种祛痘保湿霜及其制备方法 | |
CN105125466A (zh) | 一种祛斑晚霜及其制备方法 | |
CN105055992A (zh) | 用于美白去皱的中药组合物及其制备方法 | |
CN102670479B (zh) | 中药消炎拔痘美容霜及其制备方法 | |
CN105213279A (zh) | 一种消除萎缩纹的身体乳及其制备方法 | |
CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
CN105748374A (zh) | 中药嫩肤养颜美容液 | |
CN105194487A (zh) | 一种美白养颜中药组合物及其面膜和制备方法 | |
CN105213285A (zh) | 一种祛痘洗面奶及其制备方法 | |
CN101006973A (zh) | 根除皱纹营养精华液及其制备方法 | |
CN103920002A (zh) | 一种生发素及其制备方法 | |
CN115227801A (zh) | 一种防脱乌发生发液、包含其的洗发水及应用 | |
CN108785191A (zh) | 纯中药净白祛斑面霜 | |
CN102641231B (zh) | 中药十二白润肤霜及其制备方法 | |
CN109439473B (zh) | 一种祛斑美容皂及其制备方法 | |
CN105342923A (zh) | 一种预防嘴唇干裂的唇膏及其制备方法 | |
CN105687049A (zh) | 可有效去除面部暗疮的洗浴盐及制备方法 | |
CN106390061A (zh) | 一种外用防脱、育发的毛囊干细胞唤醒因子的组合物及其制备方法 | |
CN106806725A (zh) | 一种美容美白的桑葚面膜 | |
CN104524479A (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210223 Address after: 530002 no.8-1 Kunlun Avenue, Nanning, Guangxi Zhuang Autonomous Region Patentee after: GUANGXI BAIYUNSHAN YINGKANG PHARMACEUTICAL Co.,Ltd. Address before: 530003, 5 East Fourth Avenue, Garden Avenue, the Guangxi Zhuang Autonomous Region, Nanning Patentee before: NANNING GUANHUA AGRICULTURAL TECHNOLOGY Co.,Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Liang Shuhua Document name: Notification of eligibility |